Hengrui Pharma

Forecast & Rating18 analysts currently cover Hengrui Pharma, with about 100.0% giving a positive rating — meaning they expect the stock to rise. The average price target is ¥79.25, about 50.5% upside from the current price of ¥52.66. Price targets range from ¥63.00 to ¥123.00 — a wide spread, showing clear disagreement over just how much Hengrui Pharma can rise. Historically, about 46.9% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Hengrui Pharma closely still see room for the stock to rise. Data as of Aug 19, 2026; for reference only and not investment advice.